Nexalin Technology Inc (NXL) Stock Price, Quote & News

Company Profile

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 and Generation 3 headset devices for the treatment of depression, substance use disorder, traumatic brain injur...

Industry: Medical Devices

Sector: Healthcare

Phone: 832 260 0222

Website: www.nexalin.com

Address:

1776 Yorktown, Suite 550, Houston, United States

Dante_s_Inferno Aug. 7 at 7:08 AM

$NXL Nexalin Technology (NASDAQ:NXL) reported quarterly losses of $(0.10) per share. This is a 41.18 percent increase over losses of $(0.17) per share from the same period last year. The company reported $70.588 thousand in sales this quarter. This is a 163.00 percent increase over sales of $26.840 thousand the same period last year.

0 · Reply

Dante_s_Inferno Aug. 4 at 3:29 PM

$NXL 9 days red lol

0 · Reply

Dante_s_Inferno Jul. 30 at 5:58 PM

$NXL management is on vacation

0 · Reply

Painman Jul. 30 at 12:38 AM

$NXL ..And oh yeah his wife really appreciates being on the payroll for her new Mercedes!😜😆

0 · Reply

Painman Jul. 30 at 12:37 AM

$NXL ..Total scam POS founded by Same..Len Osser..Garbage 💩

0 · Reply

Chrissytina Jul. 29 at 2:26 PM

$NXL Headed back below a dollar again 😁 maybe I can get me some around $.70 again 🤷🏼‍♀️

0 · Reply

Dante_s_Inferno Jul. 25 at 6:55 AM

$NXL pos as usual

0 · Reply

LucyWalker286 Jul. 21 at 4:53 PM

$NXL is all about brand control. RMTG is doing that in the medical space—affiliates must buy exclusively from them, and they just added a new Caribbean partner.

0 · Reply

Painman Jul. 19 at 10:20 PM

$NXL ..Oh wait! I feel it now! My Balls are tingling right next to my Brain!🤪🤪

0 · Reply

Painman Jul. 19 at 10:16 PM

$NXL ..This a Pump and Dump being orchestrated by Lenny the Scumbag.. you poor bastards have already made him millions of dollars believing that you can put a stim pad on your skin and do deep brain stimulation. You should have your own brain checked if you believe that FN bullshit.

2 · Reply

Nexalin Technology Appoints Highly Experienced Financial Leader Justin Van Fleet as CFO to Support Nexalin's Next Phase of Growth and Strategic Initiatives

May 28, 2025, 10:00 AM EDT - 2 months ago

Join Nexalin Technology's Exclusive Live Investor Webinar and Q&A Session on June 3

May 13, 2025, 8:30 AM EDT - 3 months ago

Nexalin Technology Reconstitutes Scientific Advisory Board with Leading Experts to Advance Alzheimer's Program Amid Encouraging Data

May 6, 2025, 2:40 PM EDT - 3 months ago

Nexalin Technology Announces Closing of Previously Announced $5.0 Million Underwritten Public Offering

May 5, 2025, 8:20 AM EDT - 3 months ago

Nexalin Technology Announces Pricing of $5.0 Million Public Offering of Common Stock

May 1, 2025, 10:30 AM EDT - 3 months ago

Nexalin Technology Initiates FDA Q-Submission Process for Gen-2 SYNC Following Encouraging Data and Preliminary FDA Feedback

Apr 24, 2025, 9:00 AM EDT - 3 months ago

Nexalin Technology Receives IRB Approval in Brazil and Begins Clinical Trial for Anxiety and Insomnia

Apr 23, 2025, 9:15 AM EDT - 3 months ago

Nexalin Technology Announces Completion of Phases One Through Five of its Virtual Clinic and Digital Ecosystem for HALO™ Clinical Research and Patient Management

Apr 21, 2025, 8:00 AM EDT - 3 months ago

Nexalin Technology Expresses Strong Support for Health Tech Investment Act to Advance Medicare Reimbursement for AI-Enabled Devices

Apr 14, 2025, 12:30 PM EDT - 4 months ago

Nexalin Technology Secures USPTO Patent for Deep Intracranial Frequency Stimulation (DIFS™) Technology in Treating Substance Use Disorders

Apr 2, 2025, 8:30 AM EDT - 4 months ago

Nexalin Technology Enrolls First Patients and Advances Toward Treatment in UCSD Clinical Trial

Mar 26, 2025, 8:30 AM EDT - 4 months ago

Join Nexalin Technology's Exclusive Live Investor Webinar and Q&A Session on April 3

Mar 3, 2025, 8:30 AM EST - 5 months ago

Nexalin Technology Receives Notice of Allowance from the USPTO for Patent Covering Deep Intracranial Frequency Stimulation (DIFS™) Technology for Opioid and Other Substance Use Disorders

Feb 28, 2025, 8:30 AM EST - 5 months ago

Nexalin Technology Announces Initiation of Patient Recruitment for UCSD's TBI & PTSD Clinical Study Following IRB Approval

Feb 26, 2025, 8:30 AM EST - 5 months ago

Nexalin Technology Welcomes General Wesley Clark to Military & Government Advisory Board

Feb 18, 2025, 8:30 AM EST - 6 months ago

Nexalin Technology Announces UCSD IRB Approval for use of HALO™ Clarity in Clinical Trials for mTBI and PTSD Treatment

Feb 10, 2025, 9:00 AM EST - 6 months ago

Nexalin Appointed as Industry Co-Chair of National TBI Registry Coalition

Feb 3, 2025, 8:30 AM EST - 6 months ago

Nexalin's Breakthrough DIFS™ Neurostimulation Device Demonstrates Reduction in Blood Pressure while Enhancing Mental Health According to New Landmark Study

Jan 23, 2025, 11:00 AM EST - 7 months ago

Join Nexalin Technology's Exclusive Live Investor Webinar and Q&A Session, Today, January 23

Dec 23, 2024, 10:00 AM EST - 8 months ago

Nexalin Technology Completes Phase 1of its Innovative Virtual Clinic

Nov 26, 2024, 10:00 AM EST - 9 months ago

New Peer-Reviewed Publication Validates Nexalin's Deep Intracranial Frequency Stimulation (DIFS) Technology, Reinforcing Leadership in High-Growth Neuromodulation Market

Nov 1, 2024, 2:00 PM EDT - 9 months ago

Join Nexalin Technology's Exclusive Live Investor Webinar and Q&A Session on November 5th

Nov 1, 2024, 10:34 AM EDT - 9 months ago

Nexalin Technology Regains Compliance with Nasdaq Continued Listing Requirements

Nov 1, 2024, 9:00 AM EDT - 9 months ago

LOBO EV and Nexalin Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

LOBO

Oct 28, 2024, 8:30 AM EDT - 10 months ago

Nexalin Technology Announces Landmark Study on Alzheimer's Disease and Deep Intracranial Frequency Stimulation Published in Journal of Alzheimer's Disease

Oct 25, 2024, 9:00 AM EDT - 10 months ago

Nexalin Technology and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

CLDI

Oct 22, 2024, 2:15 PM EDT - 10 months ago

Nexalin Technology Announces Planned Clinical Trial Utilizing Gen-3 Halo Headset in Partnership with UC San Diego & San Diego VA

Oct 17, 2024, 8:30 AM EDT - 10 months ago

New Study Shows Nexalin's Deep Intracranial Frequency Stimulation (DIFS) Significantly Improves Memory and Cognitive Function in Alzheimer's Patients

Oct 14, 2024, 8:30 AM EDT - 10 months ago

Nexalin Technology Appoints Carolyn Shelton as Senior Vice President of Clinical, Quality & Regulatory Affairs

Sep 5, 2024, 9:00 AM EDT - 1 year ago

Nexalin Technology Participates in Congressional Roundtable Focused on Emerging Virtual Therapeutic Options for Opioid Treatment

Jul 26, 2024, 9:55 AM EDT - 1 year ago

Nexalin Interview to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

LOBO

Jul 18, 2024, 8:30 AM EDT - 1 year ago

Nexalin Technology Selected to Join Industry Coalition: Breaking Barriers to Substance Use Recovery

Jul 1, 2024, 2:45 PM EDT - 1 year ago

Nexalin Technology Announces Closing of $5.2 Million Public Offering

Jun 27, 2024, 9:15 PM EDT - 1 year ago

Nexalin Technology Announces Pricing of $5.2 Million Public Offering

Jun 20, 2024, 8:30 AM EDT - 1 year ago

Nexalin Technology Awarded Key Patent Related to its Non-Invasive, Frequency-Based Deep-Brain Stimulation Device for the Treatment of Alzheimer's and Dementia

Jun 14, 2024, 9:00 AM EDT - 1 year ago

Nexalin Technology and VolitionRX Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

VNRX

Jun 13, 2024, 3:00 PM EDT - 1 year ago

Nexalin Technology Announces Regulatory Approval to Sell Nexalin's Gen-2, 15 mA Neurostimulation Device by the Brazilian Health Regulatory Agency (Anvisa)

Jun 4, 2024, 8:30 AM EDT - 1 year ago

Nexalin Technology to Present at the Spring MicroCap Rodeo Conference on June 6th

Jun 3, 2024, 8:30 AM EDT - 1 year ago

FDA Provides Feedback and Reaches Consensus on Nexalin's Design for Planned Anxiety and Insomnia Clinical Studies of its Gen-3 HALO Clarity™ Headset Device

May 22, 2024, 8:30 AM EDT - 1 year ago

Nexalin America Selected to Join the National Traumatic Brain Injury Registry Coalition to Propel TBI Awareness and Research Efforts

Apr 10, 2024, 8:30 AM EDT - 1 year ago

Nexalin Technology CEO Provides Letter to Shareholders

Apr 4, 2024, 1:00 PM EDT - 1 year ago

Nexalin Technology Awarded Key Patent Related to its Gen-3 HALO Clarity™, a Non-Invasive, Frequency-Based Deep-Brain Stimulation Device

Apr 2, 2024, 8:30 AM EDT - 1 year ago

Nexalin Technology Announces the Appointment of Government Affairs Veteran William A. Hudson, Jr. to Military & Government Advisory Board

Mar 28, 2024, 8:30 AM EDT - 1 year ago

Nexalin Technology Announces Positive Results of Clinical Study Validating its Gen-2 tACS Device for Reducing Pain Among Veterans with Mild Traumatic Brain Injury at University of California, San Diego

Mar 14, 2024, 8:30 AM EDT - 1 year ago

Nexalin Technology Commences Sales of Gen-2 Neurostimulation Device to New Mental Health Center in Oman Dedicated to Nexalin's Technology

Mar 13, 2024, 8:30 AM EDT - 1 year ago

Nexalin Technology Announces Poster Presentation at “State of the Technology Meeting: Neurotrauma Diagnosis, Monitoring, and Assessment”

Mar 6, 2024, 8:30 AM EST - 1 year ago

Nexalin Technology Announces Positive Results from Clinical Study of its Gen-2 tACS Device for Treating Adult Patients with Chronic Insomnia

Feb 8, 2024, 8:30 AM EST - 1 year ago

Nexalin Technology Announces Regulatory Approval in Oman for Gen-2 Neurostimulation Device

Jan 23, 2024, 8:30 AM EST - 1 year ago

Nexalin Technology Awarded Key Patent Related to its Non-Invasive, Frequency-Based Deep-Brain Stimulation Device – the Transcranial Alternating Current Dynamic Frequency Stimulation (TACS) System

Jan 11, 2024, 8:30 AM EST - 1 year ago

Nexalin Technology Unveils Next-Generation HALO™ Clarity

Dante_s_Inferno Aug. 7 at 7:08 AM

0 · Reply

Dante_s_Inferno Aug. 4 at 3:29 PM

$NXL 9 days red lol

0 · Reply

Dante_s_Inferno Jul. 30 at 5:58 PM

$NXL management is on vacation

0 · Reply

Painman Jul. 30 at 12:38 AM

$NXL ..And oh yeah his wife really appreciates being on the payroll for her new Mercedes!😜😆

0 · Reply

Painman Jul. 30 at 12:37 AM

$NXL ..Total scam POS founded by Same..Len Osser..Garbage 💩

0 · Reply

Chrissytina Jul. 29 at 2:26 PM

$NXL Headed back below a dollar again 😁 maybe I can get me some around $.70 again 🤷🏼‍♀️

0 · Reply

Dante_s_Inferno Jul. 25 at 6:55 AM

$NXL pos as usual

0 · Reply

LucyWalker286 Jul. 21 at 4:53 PM

$NXL is all about brand control. RMTG is doing that in the medical space—affiliates must buy exclusively from them, and they just added a new Caribbean partner.

0 · Reply

Painman Jul. 19 at 10:20 PM

$NXL ..Oh wait! I feel it now! My Balls are tingling right next to my Brain!🤪🤪

0 · Reply

Painman Jul. 19 at 10:16 PM

2 · Reply

Dante_s_Inferno Jul. 18 at 1:50 PM

$NXL wtf

0 · Reply

NewYorkBull Jul. 16 at 7:09 PM

$NXL guys I'm a proud owner. This will change lives if you hold through next year. I promise you we'll have trial data and a lot more.

0 · Reply

Painman Jul. 9 at 6:45 PM

$NXL 💩💩💩

0 · Reply

Painman Jun. 26 at 5:16 PM

$NXL ..Total POS scam being run by Len Osser

0 · Reply

Chrissytina Jun. 25 at 1:14 PM

$NXL Anybody else noticed that since they took all these commercials off CNBC that most of them have crashed 🤣 crooks!!! Not complaining, I flipped 4 different ones 2/3 times! I want the commercials/volume to come back!!! 🙏🏻

1 · Reply

Painman Jun. 17 at 2:30 PM

$NXL ..💩💩🤪

0 · Reply

Msnlrainey May. 31 at 11:03 PM

$NXL back on tv again with red chip

0 · Reply

Painman May. 20 at 7:15 PM

$NXL Total garbage..🐕💩POS.. You can’t do deep brain stimulation or treat Alzheimer’s with skin electrodes! Check it out just another Lenny scam.

0 · Reply

TheLearnerEarner May. 15 at 3:08 PM

$NXL ✅ Healthcare - Micro Cap - Oversold F-Score: 3/9 🏦 Analysts: 1x buy rating 👨‍🔬 Potential: Revenue is forecast to grow per year 💎 Highest Analysts Price Target: $5.00 (309% above Price) 🌟 Range (12m) $0.53 - $4.49 💰 NEWSDESK (last recent article) 📰 https://www.stocktitan.net/news/NXL/nexalin-technology-reconstitutes-scientific-advisory-board-with-ja58t2vt6l1v.html

0 · Reply

Mohammed_kas May. 13 at 2:09 PM

$NXL The news is good and this is red😔

0 · Reply

Mohammed_kas May. 13 at 1:12 PM

$NXL Nexalen Technology reconstitutes its scientific advisory board with leading experts to advance its Alzheimer's program amid encouraging data.

0 · Reply

Mohammed_kas May. 12 at 6:22 PM

$NXL Added✅

0 · Reply

Market Cap	17.52M
Revenue (ttm)	170,000.00
Net Income (ttm)	-7.61M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-4,476.47%
Debt to Equity Ratio	0.00

Volume	73,719
Avg Vol	98,452
Day's Range	N/A - N/A
Shares Out	17.18M
Stochastic %K	26%
Beta	3.69
Analysts	Strong Sell
Price Target	$5.00